Can-Fite BioPharma Ltd. (CANF) › Operating IncomeCan-Fite BioPharma Ltd. (CANF) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$7.18M2018: -$5.41M2019: -$12.01M2020: -$14.14M2021: -$12.84M2022: -$10.10M2023: -$8.20M2024: -$8.13M2025: -$9.95M-$9.95M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$9.95M-22.4%2024-$8.13M+0.8%2023-$8.20M+18.8%2022-$10.10M+21.4%2021-$12.84M+9.2%2020-$14.14M-17.8%2019-$12.01M-121.8%2018-$5.41M+24.6%2017-$7.18M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share